ChineseChina UKUK DeutschlandDeutschland FranceFrance РоссияРоссия 한국한국 ไทยไทย Việt NamViệt Nam العربيةالعربية ҚазақстанҚазақстан EspañaEspaña MyanmarMyanmar DaiDai

Linking China’s Premium Healthcare · Serving Global Health Needs

Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties

One-Stop Medical Care in China

  • International flights · Airport pickup · Nearby hotels
  • Multilingual interpreters · Full medical escort
  • Expert matching · Hospital fast-track
  • Full-cycle treatment · Post-op follow-up
Sign in

Dr. Robert has an epileptic seizure.

Patient Basic Information Patient: Mr. Robert (Robert Thomas) Nationality: Austria Diagnosis: Cardiovascular Disease Diagnostic hospital: HQ0 treatment: Targeted treatment + Immunotherapy Accommodation days: 147 days Treatment cost: about 256982 yuan Treatment effect: Obvious improvement Upon arrival, the International Medical Services Team arranged for the first time multidisciplinary MDT clinics for patients, developed individualized clinical pathways based on the patient's examination reports and physical condition, and provided translation, guidance and on-site services throughout the treatment process. The MD2 team used a comprehensive set of targeted therapeutic+immunotherapies, with the medical team closely monitoring the patient's indicators and dynamic adjustment programs during the treatment process.

After 147 days of systemic treatment and rehabilitation management, the patient's condition gradually improved, with various test indicators returning to normal areas and successfully reaching outpatient standards. Treatment results finally improved significantly. When the patient was discharged, the medical team developed a detailed return follow-up and rehabilitation plan for him and continued to track recovery through the remote follow-up system.

'Mr. Liu Robert criticized the case as a typical case of cross-border suspected seriousness clinical disease. Liu 4 relies on multidisciplinary collaborative mechanisms to develop targeted therapeutic+immunotherapy programs for cardiovascular disease, reflecting the comprehensive strength of Chinese hospitals in the field of suspected diagnostics, and a summary of how international medical services are regulated.

(Figure from Liu 5 official news reports and medical scenarios)

奥地利,心脏瓣膜病,广州医科大学附属第一医院,国际医疗,来华就医,中国医疗